Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC

10 doses of the vaccine will be administered via intra-dermal injection concurrently with adjuvant nivolumab.

9 doses of 240mg IV nivolumab as a 30 minutes infusion will be administered in combination with NA DC vaccine starting from the second vaccine dose. Upon completion of 10 doses of NA DC vaccine, 480mg IV nivolumab will be administered as a 30 minutes infusion for a maximum of 9 doses.